Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive D-Cycloserine with iTBS for Fibromyalgia
NCT05395494Phase 2Terminated
- Sponsor
- University of Calgary
- Start
- Aug 2022
- Primary completion
- Jul 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing D-Cycloserine + iTBS with Placebo + iTBS (2 arms). Primary endpoint: Revised Fibromyalgia Impact Questionnaire at Week 8. Started Aug 2022; status: terminated.
02
Drugs
d-cycloserine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT05395494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05395494.